Pulmonx Revenue

Pulmonx had revenue of $22.76M in the quarter ending June 30, 2026, a decrease of -4.62%. This brings the company's revenue in the last twelve months to $87.44M, down -3.43% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth.

Revenue (ttm)

$87.44M

Revenue Growth

-3.43%

P/S Ratio

1.11

Revenue / Employee

$295,412

Employees

296

Market Cap

98.14M

Revenue Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	90.50M	6.71M	8.01%
Dec 31, 2024	83.79M	15.11M	22.01%
Dec 31, 2023	68.68M	15.01M	27.98%
Dec 31, 2022	53.66M	5.25M	10.84%
Dec 31, 2021	48.42M	15.68M	47.91%
Dec 31, 2020	32.73M	138.00K	0.42%
Dec 31, 2019	32.60M	12.59M	62.94%
Dec 31, 2018	20.00M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company Name	Revenue
Quanterix	153.41M
Outset Medical	117.80M
CVRx, Inc.	61.19M
LENSAR	60.26M
Apyx Medical	58.42M
electroCore	36.97M
Rapid Micro Biosystems	35.18M
MaxCyte	31.05M

Revenue Rankings

LUNG News

7 days ago - Pulmonx Transcript: Canaccord Genuity's 46th Annual Growth Conference - Transcripts
20 days ago - Pulmonx reports Q2 EPS (24c), consensus (28c) - TheFly
20 days ago - Pulmonx backs FY26 revenue view $90M-$92M, consensus $90.77M - TheFly
20 days ago - Pulmonx Earnings Call Transcript: Q2 2026 - Transcripts
20 days ago - Pulmonx Earnings release: Q2 2026 - Filings
20 days ago - Pulmonx Quarterly report: Q2 2026 - Filings
20 days ago - Pulmonx Reports Second Quarter 2026 Financial Results - GlobeNewsWire
21 days ago - Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference - GlobeNewsWire

More News